麻豆破解版

Start-Up of the Year Award Auvergne-Rh么ne-Alpes for Jacky Vonderscher and 麻豆破解版

Published on 18/09/2018

The 26th edition of the Entrepreneur of the year Auvergne-Rhone-Alpes took place on September 17th, 2018 in Lyon. The 鈥淪tart-Up of the Year鈥� Award has been granted to Jacky Vonderscher, CEO of 麻豆破解版. This Award recognizes the company both for its high innovation on the biotech market and its high growth leading 麻豆破解版 to become one of the leaders of tomorrow. Thus, the company reached the next step of the 鈥淓ntrepreneur of the year鈥� Award which will take place at national level on October 18th 2018 in Paris!

Read next in 'Latest news'

• Enrollment completed for our Phase 2 clinical trial in Alport syndrome
• The first patient dosed in the Phase 2 ALPESTRIA-1 clinical study of Vonafexor for Alport syndrome
• The Phase 2 ALPESTRIA-1 clinical study has started with Vonafexor on Alport syndrome
• Orphan Drug Designation (ODD) granted to Vonafexor for Alport syndrome by both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA)
• New publication: Hepatic and renal improvements with FXR agonist Vonafexor in individuals with suspected fibrotic NASH